| Mrs Taylor N Crews, MSN, APRN, PMHNP | |
|
2100 Charlie Hall Blvd, Charleston, SC 29414-5832 | |
| (843) 852-4100 | |
| Not Available |
| Full Name | Mrs Taylor N Crews |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 11 Years |
| Location | 2100 Charlie Hall Blvd, Charleston, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124300058 | NPI | - | NPPES |
| 1760596480 | Medicaid | SC |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sweetgrass Psychiatry Llc | 4688932957 | 13 |
News Archive
Transgenomic, Inc. today announced that it has been awarded a research and development grant totaling $1,070,453.32 from the U.S. government under HR: 3590 – Patient Protection and Affordable Care Act (the "Act") in immediately available funds. This is among the largest awards for any one company under the Act.
Generic anti-epilepsy drugs, pharmaceutical products similar to brand-name versions, save consumers billions of dollars each year, but some are different enough from branded formulations that they may not be effective, particularly if patients switch between two generic drugs, a new study by Johns Hopkins researchers suggests. A report on the study, published online and in an upcoming issue of Annals of Neurology, raises questions about whether some generic products are safe and effective when a narrow dose range separates patients from help and harm.
If a patient contracts an infection while in the hospital, each day of hospitalization increases by 1% the likelihood that the infection will be multidrug-resistant, according to research presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) an infectious disease meeting of the American Society for Microbiology.
Acute postoperative pain control after Total Knee Arthroplasty is important as the poorly controlled, persistent pain can cause delay in rehabilitation.
Halozyme Therapeutics, Inc. today announced insulin variability study results that demonstrated reduced intrasubject absorption variability for the combination of lispro, a meal time analog insulin, plus PH20 (hyaluronidase) compared to subcutaneous injection of lispro alone.
› Verified 7 days ago
| Entity Name | South Carolina Dept Of Mental Health Accounting Office |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760596480 PECOS PAC ID: 9032021175 Enrollment ID: O20031215000552 |
News Archive
Transgenomic, Inc. today announced that it has been awarded a research and development grant totaling $1,070,453.32 from the U.S. government under HR: 3590 – Patient Protection and Affordable Care Act (the "Act") in immediately available funds. This is among the largest awards for any one company under the Act.
Generic anti-epilepsy drugs, pharmaceutical products similar to brand-name versions, save consumers billions of dollars each year, but some are different enough from branded formulations that they may not be effective, particularly if patients switch between two generic drugs, a new study by Johns Hopkins researchers suggests. A report on the study, published online and in an upcoming issue of Annals of Neurology, raises questions about whether some generic products are safe and effective when a narrow dose range separates patients from help and harm.
If a patient contracts an infection while in the hospital, each day of hospitalization increases by 1% the likelihood that the infection will be multidrug-resistant, according to research presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) an infectious disease meeting of the American Society for Microbiology.
Acute postoperative pain control after Total Knee Arthroplasty is important as the poorly controlled, persistent pain can cause delay in rehabilitation.
Halozyme Therapeutics, Inc. today announced insulin variability study results that demonstrated reduced intrasubject absorption variability for the combination of lispro, a meal time analog insulin, plus PH20 (hyaluronidase) compared to subcutaneous injection of lispro alone.
› Verified 7 days ago
| Entity Name | Sweetgrass Psychiatry Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669985859 PECOS PAC ID: 4688932957 Enrollment ID: O20171213002990 |
News Archive
Transgenomic, Inc. today announced that it has been awarded a research and development grant totaling $1,070,453.32 from the U.S. government under HR: 3590 – Patient Protection and Affordable Care Act (the "Act") in immediately available funds. This is among the largest awards for any one company under the Act.
Generic anti-epilepsy drugs, pharmaceutical products similar to brand-name versions, save consumers billions of dollars each year, but some are different enough from branded formulations that they may not be effective, particularly if patients switch between two generic drugs, a new study by Johns Hopkins researchers suggests. A report on the study, published online and in an upcoming issue of Annals of Neurology, raises questions about whether some generic products are safe and effective when a narrow dose range separates patients from help and harm.
If a patient contracts an infection while in the hospital, each day of hospitalization increases by 1% the likelihood that the infection will be multidrug-resistant, according to research presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) an infectious disease meeting of the American Society for Microbiology.
Acute postoperative pain control after Total Knee Arthroplasty is important as the poorly controlled, persistent pain can cause delay in rehabilitation.
Halozyme Therapeutics, Inc. today announced insulin variability study results that demonstrated reduced intrasubject absorption variability for the combination of lispro, a meal time analog insulin, plus PH20 (hyaluronidase) compared to subcutaneous injection of lispro alone.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Taylor N Crews, MSN, APRN, PMHNP 2100 Charlie Hall Blvd, Charleston, SC 29414-5832 Ph: () - | Mrs Taylor N Crews, MSN, APRN, PMHNP 2100 Charlie Hall Blvd, Charleston, SC 29414-5832 Ph: (843) 852-4100 |
News Archive
Transgenomic, Inc. today announced that it has been awarded a research and development grant totaling $1,070,453.32 from the U.S. government under HR: 3590 – Patient Protection and Affordable Care Act (the "Act") in immediately available funds. This is among the largest awards for any one company under the Act.
Generic anti-epilepsy drugs, pharmaceutical products similar to brand-name versions, save consumers billions of dollars each year, but some are different enough from branded formulations that they may not be effective, particularly if patients switch between two generic drugs, a new study by Johns Hopkins researchers suggests. A report on the study, published online and in an upcoming issue of Annals of Neurology, raises questions about whether some generic products are safe and effective when a narrow dose range separates patients from help and harm.
If a patient contracts an infection while in the hospital, each day of hospitalization increases by 1% the likelihood that the infection will be multidrug-resistant, according to research presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) an infectious disease meeting of the American Society for Microbiology.
Acute postoperative pain control after Total Knee Arthroplasty is important as the poorly controlled, persistent pain can cause delay in rehabilitation.
Halozyme Therapeutics, Inc. today announced insulin variability study results that demonstrated reduced intrasubject absorption variability for the combination of lispro, a meal time analog insulin, plus PH20 (hyaluronidase) compared to subcutaneous injection of lispro alone.
› Verified 7 days ago
Marsha Susan Voges, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4115 Dorchester Road, Concentra Medical Center, Charleston, SC 29405 Phone: 843-554-6737 Fax: 843-554-3356 | |
Mrs. Pamela Staker, MSN, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 109 Bee St, Charleston, SC 29401 Phone: 843-577-5011 | |
Karen D Doll, ANP, CVNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: Medical University Of South Carolina, 114 Doughty Street Suite 654, Charleston, SC 29424 Phone: 843-876-4854 Fax: 843-876-4413 | |
Julie Mackay Hughes, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2070 Northbook Blvd, Ste A16, Charleston, SC 29405 Phone: 843-818-6102 | |
Kristen Slagel Garrett, CPNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2051 Charlie Hall Blvd, Charleston, SC 29414 Phone: 843-573-2535 Fax: 843-573-2534 | |
Lindsey Hendrickson, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Mrs. Erin Kosak, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 109 Wappoo Creek Dr, Charleston, SC 29412 Phone: 843-796-7171 Fax: 843-795-7171 |